Hartung HP - Search Results

1

Retinal pathology in Susac syndrome detected by spectral-domain optical coherence tomography.

Ringelstein M, Albrecht P, Kleffner I, Bühn B, Harmel J, Müller AK, Finis D, Guthoff R, Bergholz R, Duning T, Krämer M, Paul F, Brandt A, Oberwahrenbrock T, Mikolajczak J, Wildemann B, Jarius S, Hartung HP, Aktas O, Dörr J. Ringelstein M, et al. Among authors: hartung hp. Neurology. 2015 Aug 18;85(7):610-8. doi: 10.1212/WNL.0000000000001852. Epub 2015 Jul 22. Neurology. 2015. PMID: 26203089

2

Current disease-modifying therapies in multiple sclerosis.

Kieseier BC, Hartung HP. Kieseier BC, et al. Among authors: hartung hp. Semin Neurol. 2003 Jun;23(2):133-46. doi: 10.1055/s-2003-41138. Semin Neurol. 2003. PMID: 12894379 Review.

3

Cyclo-oxygenases and prostaglandins in acute inflammatory demyelination of the peripheral nerve.

Hu W, Mathey E, Hartung HP, Kieseier BC. Hu W, et al. Among authors: hartung hp. Neurology. 2003 Dec 23;61(12):1774-9. doi: 10.1212/01.wnl.0000098884.75756.4d. Neurology. 2003. PMID: 14694045

4

Are statins a treatment option for multiple sclerosis?

Neuhaus O, Stüve O, Zamvil SS, Hartung HP. Neuhaus O, et al. Among authors: hartung hp. Lancet Neurol. 2004 Jun;3(6):369-71. doi: 10.1016/S1474-4422(04)00770-7. Lancet Neurol. 2004. PMID: 15157852 Review.

5

Different effects of simvastatin and interferon beta on the proteolytic activity of matrix metalloproteinases.

Kieseier BC, Archelos JJ, Hartung HP. Kieseier BC, et al. Among authors: hartung hp. Arch Neurol. 2004 Jun;61(6):929-32. doi: 10.1001/archneur.61.6.929. Arch Neurol. 2004. PMID: 15210533

6

Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis.

Cepok S, Rosche B, Grummel V, Vogel F, Zhou D, Sayn J, Sommer N, Hartung HP, Hemmer B. Cepok S, et al. Among authors: hartung hp. Brain. 2005 Jul;128(Pt 7):1667-76. doi: 10.1093/brain/awh486. Epub 2005 Mar 30. Brain. 2005. PMID: 15800022

7

Immune response to immunotherapy: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosis.

Hemmer B, Stüve O, Kieseier B, Schellekens H, Hartung HP. Hemmer B, et al. Among authors: hartung hp. Lancet Neurol. 2005 Jul;4(7):403-12. doi: 10.1016/S1474-4422(05)70117-4. Lancet Neurol. 2005. PMID: 15963443 Review.

8

Clinical stabilization and effective B-lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis.

Stüve O, Cepok S, Elias B, Saleh A, Hartung HP, Hemmer B, Kieseier BC. Stüve O, et al. Among authors: hartung hp. Arch Neurol. 2005 Oct;62(10):1620-3. doi: 10.1001/archneur.62.10.1620. Arch Neurol. 2005. PMID: 16216948

9

Immunopathogenesis and immunotherapy of multiple sclerosis.

Hemmer B, Nessler S, Zhou D, Kieseier B, Hartung HP. Hemmer B, et al. Among authors: hartung hp. Nat Clin Pract Neurol. 2006 Apr;2(4):201-11. doi: 10.1038/ncpneuro0154. Nat Clin Pract Neurol. 2006. PMID: 16932551 Review.

10

Interferon-beta and neuroprotection in multiple sclerosis--facts, hopes and phantasies.

Kieseier BC, Hartung HP. Kieseier BC, et al. Among authors: hartung hp. Exp Neurol. 2007 Jan;203(1):1-4. doi: 10.1016/j.expneurol.2006.09.007. Epub 2006 Oct 25. Exp Neurol. 2007. PMID: 17069803 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,122 results

Search Page